27. 28. 29.30. 31. 32.Turgeman, G. The therapeutic potential of mesenchymal stem cells in Alzheimer’s illness: Converging mechanisms. Neural. Regen. Res. 2015, 10, 69899. [CrossRef] Gugliandolo, A.; Bramanti, P.; Mazzon, E. Mesenchymal stem cell therapy in Parkinson’s illness animal models. Curr. Res. Transl. Med. 2017, 65, 510. [CrossRef] Zhang, C.; Zhou, C.; Teng, J.J.; Zhao, R.L.; Song, Y.Q.; Zhang, C. Several administrations of human marrow stromal cells via cerebrospinal fluid prolong survival inside a transgenic mouse model of amyotrophic lateral sclerosis. Cytotherapy 2009, 11, 29906. [CrossRef] Teixeira, F.G.; Carvalho, M.M.; Panchalingam, K.M.; Rodrigues, A.J.; Mendes-Pinheiro, B.; Anjo, S.; Manadas, B.; Behie, L.A.; Sousa, N.; Salgado, A.J. Influence on the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior inside a Rat Model of Parkinson’s Disease. Stem Cells Transl. Med. 2017, 6, 63446. [CrossRef] Joshi, M.; Patil, P.B.; He, Z.; Holgersson, J.; Olausson, M.; Sumitran-Holgersson, S. Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes.Solanezumab Cytotherapy 2012, 14, 65769. [CrossRef] Si, Y.L.; Zhao, Y.L.; Hao, H.J.; Fu, X.B.; Han, W.D. MSCs: Biological traits, clinical applications and their outstanding concerns. Ageing Res. Rev. 2011, 10, 9303. [CrossRef] In ‘t Anker, P.S.; Scherjon, S.A.; Kleijburg-van der Keur, C.; de Groot-Swings, G.M.; Claas, F.H.; Fibbe, W.E.; Kanhai, H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22, 1338345. [CrossRef] da Silva Meirelles, L.; Caplan, A.I.; Nardi, N.B. In search of your in vivo identity of mesenchymal stem cells.Garetosmab Stem Cells 2008, 26, 2287299.PMID:23756629 [CrossRef] Employees, N.P.; Jones, D.T.; Singer, W. Mesenchymal Stromal Cell Therapies for Neurodegenerative Ailments. Mayo Clin. Proc. 2019, 94, 89205. [CrossRef] Paul, G.; Anisimov, S.V. The secretome of mesenchymal stem cells: Possible implications for neuroregeneration. Biochimie 2013, 95, 2246256. [CrossRef] Correia, J.S.; Neves-Carvalho, A.; Mendes-Pinheiro, B.; Pires, J.; Teixeira, F.G.; Lima, R.; Monteiro, S.; Silva, N.A.; Soares-Cunha, C.; Serra, S.C.; et al. Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Kind 3. Biomedicines 2021, 9, 1754. [CrossRef] Li, T.; Liu, Y.; Yu, L.; Lao, J.; Zhang, M.; Jin, J.; Lu, Z.; Liu, Z.; Xu, Y. Human Umbilical Cord Mesenchymal Stem Cells Protect Against SCA3 by Modulating the Amount of 70 kD Heat Shock Protein. Cell Mol. Neurobiol. 2018, 38, 64155. [CrossRef] Chang, Y.K.; Chen, M.H.; Chiang, Y.H.; Chen, Y.F.; Ma, W.H.; Tseng, C.Y.; Soong, B.W.; Ho, J.H.; Lee, O.K. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells. J. Biomed. Sci. 2011, 18, 54. [CrossRef] Hong, J.; Yoon, D.; Nam, Y.; Seo, D.; Kim, J.H.; Kim, M.S.; Lee, T.Y.; Kim, K.S.; Ko, P.W.; Lee, H.W.; et al. Lipopolysaccharide administration for any mouse model of cerebellar ataxia with neuroinflammation. Sci. Rep. 2020, ten, 13337. [CrossRef] Nam, Y.; Yoon, D.; Hong, J.; Kim, M.S.; Lee, T.Y.; Kim, K.S.; Lee, H.W.; Suk, K.; Kim, S.R. Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation. J. Clin. Med. 2020, 9, 3654. [CrossRef] Carballo-Pedrares, N.; Sanjurjo-Rodriguez, C.; Senaris, J.; Diaz-Prado, S.; Rey-Rico, A. Chondrogenic Differentiation of.
